US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 1.490
  • -0.010-0.67%
Close Oct 2 16:00 ET
  • 1.490
  • 0.0000.00%
Post 20:01 ET
76.76MMarket Cap-1552P/E (TTM)

PMV Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
0.24%20.17M
-15.17%18.22M
4.01%80.13M
-10.68%18.9M
1.31%19.63M
12.51%20.12M
15.37%21.48M
32.16%77.04M
14.56%21.16M
28.34%19.38M
Selling and administrative expenses
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
5.83%6.04M
-2.24%6.28M
-5.54%6.41M
14.92%25.05M
-2.66%6.14M
-3.81%5.71M
-General and administrative expense
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
5.83%6.04M
-2.24%6.28M
-5.54%6.41M
14.92%25.05M
-2.66%6.14M
-3.81%5.71M
Research and development costs
5.67%14.63M
-12.52%13.19M
7.50%55.89M
-10.94%13.38M
-0.59%13.59M
20.77%13.84M
27.35%15.07M
42.46%51.99M
23.49%15.03M
49.16%13.67M
Operating profit
-0.24%-20.17M
15.17%-18.22M
-4.01%-80.13M
10.68%-18.9M
-1.31%-19.63M
-12.51%-20.12M
-15.37%-21.48M
-32.16%-77.04M
-14.56%-21.16M
-28.34%-19.38M
Net non-operating interest income expense
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
165.48%2.98M
346.36%2.7M
915.28%2.33M
707.80%3.63M
1,595.28%1.8M
1,001.96%1.12M
Non-operating interest income
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
165.48%2.98M
346.36%2.7M
915.28%2.33M
707.80%3.63M
1,595.28%1.8M
1,001.96%1.12M
Other net income (expense)
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
-69.23%4K
80.65%-6K
165.85%27K
314.29%87K
185.71%20K
333.33%13K
Other non- operating income (expenses)
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
-69.23%4K
80.65%-6K
165.85%27K
314.29%87K
185.71%20K
333.33%13K
Income before tax
0.26%-17.39M
20.17%-15.27M
5.96%-68.96M
18.55%-15.76M
8.76%-16.64M
-0.69%-17.43M
-3.78%-19.13M
-26.81%-73.33M
-5.37%-19.35M
-21.65%-18.24M
Income tax
-404,425.00%-16.17M
0
122.22%2K
-1K
0
300.00%4K
0
-139.13%-9K
0
-147.37%-9K
Net income
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
-21.44%-18.23M
Net income continuous Operations
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
-21.44%-18.23M
Minority interest income
Net income attributable to the parent company
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
-21.44%-18.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
-21.44%-18.23M
Basic earnings per share
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
15.00%-0.34
0.00%-0.38
-2.44%-0.42
-25.78%-1.61
-7.50%-0.43
-21.21%-0.4
Diluted earnings per share
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
15.00%-0.34
0.00%-0.38
-2.44%-0.42
-25.78%-1.61
-7.50%-0.43
-21.21%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 0.24%20.17M-15.17%18.22M4.01%80.13M-10.68%18.9M1.31%19.63M12.51%20.12M15.37%21.48M32.16%77.04M14.56%21.16M28.34%19.38M
Selling and administrative expenses -11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M5.83%6.04M-2.24%6.28M-5.54%6.41M14.92%25.05M-2.66%6.14M-3.81%5.71M
-General and administrative expense -11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M5.83%6.04M-2.24%6.28M-5.54%6.41M14.92%25.05M-2.66%6.14M-3.81%5.71M
Research and development costs 5.67%14.63M-12.52%13.19M7.50%55.89M-10.94%13.38M-0.59%13.59M20.77%13.84M27.35%15.07M42.46%51.99M23.49%15.03M49.16%13.67M
Operating profit -0.24%-20.17M15.17%-18.22M-4.01%-80.13M10.68%-18.9M-1.31%-19.63M-12.51%-20.12M-15.37%-21.48M-32.16%-77.04M-14.56%-21.16M-28.34%-19.38M
Net non-operating interest income expense 3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M165.48%2.98M346.36%2.7M915.28%2.33M707.80%3.63M1,595.28%1.8M1,001.96%1.12M
Non-operating interest income 3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M165.48%2.98M346.36%2.7M915.28%2.33M707.80%3.63M1,595.28%1.8M1,001.96%1.12M
Other net income (expense) -183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K-69.23%4K80.65%-6K165.85%27K314.29%87K185.71%20K333.33%13K
Other non- operating income (expenses) -183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K-69.23%4K80.65%-6K165.85%27K314.29%87K185.71%20K333.33%13K
Income before tax 0.26%-17.39M20.17%-15.27M5.96%-68.96M18.55%-15.76M8.76%-16.64M-0.69%-17.43M-3.78%-19.13M-26.81%-73.33M-5.37%-19.35M-21.65%-18.24M
Income tax -404,425.00%-16.17M0122.22%2K-1K0300.00%4K0-139.13%-9K0-147.37%-9K
Net income 93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M-21.44%-18.23M
Net income continuous Operations 93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M-21.44%-18.23M
Minority interest income
Net income attributable to the parent company 93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M-21.44%-18.23M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M-21.44%-18.23M
Basic earnings per share 94.74%-0.0228.57%-0.310.56%-1.4427.91%-0.3115.00%-0.340.00%-0.38-2.44%-0.42-25.78%-1.61-7.50%-0.43-21.21%-0.4
Diluted earnings per share 94.74%-0.0228.57%-0.310.56%-1.4427.91%-0.3115.00%-0.340.00%-0.38-2.44%-0.42-25.78%-1.61-7.50%-0.43-21.21%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data